Contineum Therapeutics, Inc. · NASDAQ:CTNM

BlackRock, Inc. reported a 6.30% stake in Contineum Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 27, 2026

BlackRock, Inc. reported a 6.30% stake in Contineum Therapeutics, Inc., 2,049,493 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).

Stake
6.30%
Shares
2,049,493
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.6.30%2,049,493

Source

View original at SEC

Related